SM
ALPN

Sabby Management’s Alpine Immune Sciences Inc ALPN Stock Holding History

Sabby Management’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-10,001
Closed -$90K – 329
2016
Q4 		$90K Sell
10,001
-56,912
-85% -$1.13M 0.01% 270
2016
Q3 		$2.18M Sell
66,913
-93,460
-58% -$2.28M 0.08% 123
2016
Q2 		$2.95M Sell
160,373
-5,142
-3% -$91.3K 0.15% 82
2016
Q1 		$2.76M Buy
165,515
+39,616
+31% +$793K 0.14% 78
2015
Q4 		$3.9M Buy
125,899
+29,715
+31% +$1.01M 0.21% 74
2015
Q3 		$4.99M Sell
96,184
-11,326
-11% -$744K 0.21% 84
2015
Q2 		$6.51M Buy
+107,510
New +$6.4M 0.24% 79

Other funds holding ALPN

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Sabby Management's ALPN Position: Q1 2017 in Review

Sabby Management sold out of Alpine Immune Sciences Inc (ALPN) in Q1 2017, closing a stake of 10,001 shares — an estimated $90K sold.

Sabby Management first reported a position in ALPN in Q2 2015 and held it in 7 quarters. The position peaked at $6.51M in Q2 2015. 28 funds tracked by Wall St. Rank hold ALPN as of Q1 2017.

  • Sabby Management reported no remaining Alpine Immune Sciences Inc position as of Q1 2017 after selling out during the quarter.
  • Sabby Management sold 10,001 Alpine Immune Sciences Inc shares in Q1 2017, an estimated $90K.
  • Sabby Management first reported a position in Alpine Immune Sciences Inc in Q2 2015 and held it in 7 quarters.
  • Sabby Management's Alpine Immune Sciences Inc position peaked at $6.51M in Q2 2015.
  • 28 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q1 2017.

Based on Sabby Management's 13F filing for Q1 2017, filed 15 May 2017.